Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBBQ vs. SHPAX: which is better?

Bottom line

IBBQ vs SHPAX: the short answer

IBBQ (Invesco Nasdaq Biotechnology ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 24% of their top holdings (by weight) are shared.

But IBBQ is far broader, holding 261 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.

IBBQ is cheaper at 0.19% vs 3% — a difference of $281 a year per $10,000 invested.

Over one year, IBBQ returned −0.6% vs −5.5% for SHPAX.

SHPAX has a front-end sales load of up to 5.75%; the other does not.

Updated Nov 19, 2026

IBBQ vs SHPAX side by side

IBBQSHPAX
TypeETFMutual fund
Fund familyInvescoSaratoga Advantage
CategoryTechnology SectorTechnology Sector
Expense ratio0.19%3%
Annual cost per $10k$19$300
10-yr cost on $10k (prospectus)$242$3,702
Max front loadNone5.75%
12b-1 fee——
1-yr return−0.6%−5.5%
5-yr return (annualized)—+3.1%
10-yr return (annualized)—+4.1%
Best quarter+12.0%+15.0%
Worst quarter−11.7%−13.0%
Net assets (fund)$67.4M$10.5M
Number of holdings26129
Portfolio turnover17%22%
Returns as ofDec 31, 2024Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBBQSHPAXDifference
2024−0.6%+0.3%−0.9%
2023+4.5%−0.4%+4.9%
2022−10.2%+2.0%−12.3%

Source: Fund prospectus bar charts

Holdings overlap

8 of IBBQ's top 25 holdings also appear in SHPAX's top 25.

Shared top holdings
HoldingIBBQSHPAX
Gilead Sciences, Inc.7.39%3.94%
Vertex Pharmaceuticals Inc.7.38%3.36%
Amgen Inc.7.10%5.04%
Regeneron Pharmaceuticals, Inc.5.08%3.93%
United Therapeutics Corp.1.94%6.17%
Incyte Corp.1.53%2.89%
Jazz Pharmaceuticals PLC1.16%6.19%
Exelixis, Inc.1.04%4.55%

Source: SEC Form N-PORT

IBBQ top 10

  1. Invesco Private Prime Fund — 14.20%
  2. Gilead Sciences, Inc. — 7.39%
  3. Vertex Pharmaceuticals Inc. — 7.38%
  4. Amgen Inc. — 7.10%
  5. Invesco Private Government Fund — 5.48%
  6. Regeneron Pharmaceuticals, Inc. — 5.08%
  7. Alnylam Pharmaceuticals, Inc. — 3.19%
  8. Revolution Medicines, Inc. — 2.48%
  9. Biogen Inc. — 2.29%
  10. Illumina, Inc. — 1.98%

SHPAX top 10

  1. Cardinal Health Inc — 6.44%
  2. Jazz Pharmaceuticals Plc — 6.19%
  3. United Therapeutics Corp — 6.17%
  4. Amgen Inc — 5.04%
  5. Mckesson Corp — 4.90%
  6. Lantheus Holdings Inc — 4.64%
  7. Exelixis Inc — 4.55%
  8. Novartis Ag — 4.50%
  9. Cencora Inc — 4.33%
  10. Gilead Sciences Inc — 3.94%

FAQ

What is the difference between IBBQ and SHPAX?
IBBQ (Invesco Nasdaq Biotechnology ETF) and SHPAX (Health & Biotechnology Portfolio) are quite different portfolios: only about 24% of their top holdings (by weight) are shared. But IBBQ is far broader, holding 261 positions to 29 for SHPAX, so beyond the top names it adds exposure SHPAX doesn't have.
Which is cheaper, IBBQ or SHPAX?
IBBQ has the lower expense ratio (0.19%).
Should I own both IBBQ and SHPAX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.